← SynDRA
RX-518
SynDRA canonical compound SYN0039632 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | EGFR |
| Mechanism of action | EGFR inhibitor |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- Olafertinib
- CK-101
- IDRGFNPZDVBSSE-UHFFFAOYSA-N
- RX 518
- N-(3-(2-((2,3-Difluoro-4-(4-(2-hydroxyethyl)piperazin-1-yl)phenyl)amino)quinazolin-8-yl)phenyl)acrylamide
- EGFR-IN-3
- UNII-708TLB8J3Y
- 708TLB8J3Y
- AK543910
- N-[3-[2-[[2,3-difluoro-4-[4-(2-hydroxyethyl)piperazin-1-yl]phenyl]amino]quinazolin-8-yl]phenyl]acrylamide
- GTPL9863
- SCHEMBL16514522
- KS-00000TOQ
- MolPort-042-663-562
- RX518
- CK101
- EX-A1142
- BCP19075
- ZINC514250913
- AKOS030632731
- DS-19272
- HY-19815
- CS-0016788
- Example 153 [US20170050936A1]
- J-690231
- 2-Propena
- CK 101
- OLAFERTINIB [INN]
- OLAFERTINIB [WHO-DD]
- Example 153 (US20170050936A1)
- RefChem:168052
- EGFR Mutant-specific Inhibitor CK-101
- MFCD30345533
- C29H28F2N6O2
- orb1296096
- SCHEMBL29369343
- SCHEMBL29623752
- SCHEMBL30341859
Look up RX-518 in the interactive SynDRA portal →